Regular screening for and early detection of breast cancer is indisputably the best defense against this pervasive disease. And of course, patients want the best and most effective screening and diagnostic technology available to them.
Research studies continue to affirm the advantages of DBT over 2D mammography in better detection – especially for the most lethal cancers – and reduced call backs. Insurance coverage for DBT is becoming widespread, especially in the U.S., aided by state-level mandates in many cases. Medicare began covering DBT in 2015.
In the early days, the upfront investment required to offer DBT interpretations was prohibitive for many imaging operations. The cost of acquiring and maintaining specialized workstations, plus the productivity hit of introducing a tangential workflow and new skillset to the users of those costly workstations, was a significant barrier to entry.
Today, this barrier has been eliminated because the availability of all-in-one integrated breast imaging workflow solutions removes the need to invest in specialized hardware and software. What used to require a separate workflow and a separate, high-end workstation – perhaps in another room or even at another facility – can now be accomplished from the same fully-featured diagnostic viewer on all the same machines used for other interpretations and modalities.